ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke

Neuroscience Letters

Volumn 398, Issue 3, 2006, Pages 167-171

  Fernández Cadenas, Israel ^a   Molina, Carlos Alberto ^a   Álvarez Sabín, José ^a   Ribó, Marc ^a   Penalba, Anna ^a   Ortega Torres, Laura ^a   Delgado, Pilar ^a   Quintana, Manolo ^a   Rosell, Anna ^a   Montaner, Joan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

ACE I D polymorphism; Genes; Hemorrhagic transformation; Recanalization; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; BLEEDING DISORDER; BLOOD CLOT LYSIS; BLOOD SAMPLING; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA POLYMORPHISM; DOPPLER ECHOGRAPHY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECANALIZATION; STROKE; TIME;

ACUTE DISEASE; AGED; BRAIN; FACTOR VII; FACTOR X; FEMALE; FIBRINOLYTIC AGENTS; GENOTYPE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MUSCLE RELAXATION; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, GENETIC; RENIN; SEQUENCE DELETION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33646484228     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.12.079     Document Type: Article

References (25)

1. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., and Marsh III E.E. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
2. Brott T.G., Haley E.C., Levy D.E., Barsan W., Broderick J., Sheppard G.L., Spilker J., Kongable G.L., Massey S., and Reed R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23 (1992) 632-640
3. Burgin W.S., Malkoff M., Felberg R.A., Demchuk A.M., Christou I., Grotta J.C., and Alexandrov A.V. Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 30 (2000) 1128-1132
4. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-gelas F., and Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359 (1992) 641-654
5. Demchuk A.M., Tanne D., Hill M.D., Kasner S.E., Hanson S., Grond M., and Levine S.R. mMulticentre tPA Stroke Survey Group. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 57 (2001) 474-480
6. Fernandez-Llama P., Poch E., Oriola J., Botey A., de la Sierra A., Revert L., Rivera F., and Darnell A. Genetic polymorphisms of the renin-angiotensin system and essential hypertension. Med. Clin. (Barc.) 112 (1999) 561-564
7. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Hoxter G., and Mahagne M.H. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
8. Karagiannis A., Balaska K., Tziomalos K., Tokalaki-Nikolaidou L., Papayeoryiou A., and Zamboulis C. Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur. Neurol. 51 (2004) 148-152
9. Margaglione M., Grandone E., Vecchione G., Cappucci G., Giuliani N., Colaizzo D., Celentano E., Panico S., and Di Minno G. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2082-2087
10. Molina C.A., Montaner J., Abilleira S., Arenillas J.F., Ribo M., Huertas R., Romero F., and Alvarez-Sabin J. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 32 (2001) 2821-2827
11. Moore J.H., Smolkin M.E., Lamb J.M., Brown N.J., and Vaughan D.E. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms. Clin. Genet. 62 (2002) 53-59
12. Okura Y., Hayashi K., Shingu T., Kuga Y., Nomura S., Kajiyama G., Nakashima Y., and Saku K. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism. Coron. Artery Dis. 14 (2003) 285-291
13. Pessin M., del Zoppo G., and Estol C. Thrombolytic agents in the treatment of stroke. Clin. Neuropharmacol. 13 (1990) 271-289
14. Ribo M., Montaner J., Molina C.A., Arenillas J.F., Santamarina E., and Alvarez-Sabin J. Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thromb. Haemost. 91 (2004) 1146-1151
15. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1356
16. Saeed M., Slowik A., Borratynska A., Dziedzic T., Szczudlik A., and Kieltyka A. ACE and subarachnoid hemorrhage: strategies for genetics of stroke. Stroke 35 (2004) 2752-2753
17. Schmidt S., van Hooft I.M., Grobbee D.E., Ganten D., and Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J. Hypertens. 11 (1993) 345-348
18. Schunkert H., Hense H.W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., and Riegger G.A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330 (1994) 1634-1638
19. Seino Y., Ikeda U., Maeda Y., Haga Y., Yashima H., and Shimada K. Angiotensin-converting enzyme gene polymorphism and plasminogen activator inhibitor 1 levels in subjects with cerebral infarction. J. Thromb. Thrombolysis 5 (1998) 263-267
20. Shanmugam V., Sell S.K., and Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3 (1993) 120-131
21. Slowik A., Turaj W., Dziedzic T., Haefele A., Pera J., Malecki M.T., Glodzik-Sobanska L., Szermer P., Figlewicz D.A., and Szczudlik A. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 63 (2004) 359-361
22. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., and Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51 (1992) 197-205
23. Tkac I., Salagovic J., Kozarova M., Javorsky M., Tkacova R., and Kalina I. Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus. Wien Klin Wochenschr. 115 (2003) 835-839
24. Wardlaw J.M., Warlow C.P., and Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 350 (1997) 607-614
25. Zhu X., Bouzekri N., Southam L., Cooper R.S., Adeyemo A., McKenzie C.A., Luke A., Chen G., Elston R.C., and Ward R. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am. J. Hum. Genet. 68 (2001) 1139-1148